ICICI Securities Ltd | Retail Equity Research Revenues increased 16% YoY to | 1634 crore (I-direct estimate: | 1499 crore) on the back of 22% YoY increase in pharmacy business to | 710 crore (I-direct estimate: | 652 crore) and 12% YoY increase in healthcare business to | 924 crore (I-direct estimate: | 847 crore) EBITDA margins were at 13.6% (-34 bps YoY) vs. I-direct estimate of 12.8% due to higher-than-expected margins in new hospitals (9%) Adjusted net profit grew mere 2.7% to | 92 crore (I-direct estimate:...